Several outpatient models for the follow-up of cancer survivors have been developed worldwide. A multidisciplinary approach is often necessary to guarantee the best monitoring of long-term toxicities. Guidelines also indicate a close education on healthy lifestyles. In this context, we have analyzed the Italian follow-up modalities of lymphoma survivors, with the aim to have a starting line to hypothesize and plan the best model for Italian hematology centers.
MinoiaCCiavarellaSLerarioG, et al. Improvable lifestyle factors in lymphoma survivors. Acta Haematol2018; 139: 235–237.
2.
CiavarellaSMinoiaCQuintoAM, et al. Improving provision of care for long-term survivors of lymphoma. Clin Lymphoma Myeloma Leuk2017; 17: e1–e9.
3.
NekhlyudovLO’MalleyDMHudsonSV.Integrating primary care providers in the care of cancer survivors: gaps in evidence and future opportunities. Lancet Oncol2017; 18: e30–e38.
4.
ParkerPABanerjeeSCMatasarMJ, et al. Efficacy of a survivorship-focused consultation versus a time-controlled rehabilitation consultation in patients with lymphoma: a cluster randomized controlled trial. Cancer2018; 124: 4567–4576.
5.
ViscusePYostKJJenkinsS, et al. Impact of lymphoma survivorship clinic visit on patient-centered outcomes. J Cancer Surviv2019; 13: 344–352.
6.
TaylorKJoskeDBulsaraM, et al. Protocol for Care After Lymphoma (CALy) trial: a phase II pilot randomised controlled trial of a lymphoma nurse-led model of survivorship care. BMJ Open2016; 6: e010817.
7.
JohnCArmesJ.Developing a nurse-led survivorship service for patients with lymphoma. Eur J Oncol Nurs2013; 17: 521–527.
8.
SmithTGDunnMELevinKY, et al. Cancer survivor perspectives on sharing patient-generated health data with central cancer registries. Qual Life Res2019; 28: 2957–2967.
9.
HathiramaniSPettengellRMoirH, et al. Lymphoma survivors’ experience of participation in a home-based intervention post-chemotherapy. Qual Life Res2019; 28: 2951–2955.
10.
KlineRMAroraNKBradleyCJ, et al. Long-term survivorship care after cancer treatment: summary of a 2017 National Cancer Policy Forum Workshop. J Natl Cancer Inst2018; 110: 1300–1310.
